Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

188.87 -0.18 (-0.10%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,791,712
Open 187.46
Bid (Size) 187.21 (1)
Ask (Size) 190.00 (2)
Prev. Close 189.05
Today's Range 186.76 - 189.50
52wk Range 140.68 - 194.48
Shares Outstanding 2,628,679,824
Dividend Yield 2.75%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant... 
Via MarketMinute
Topics Intellectual Property
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of... 
Via TokenRing AI
Topics Artificial Intelligence Supply Chain

Performance

YTD
+31.1%
+31.1%
1 Month
+1.5%
+1.5%
3 Month
+12.9%
+12.9%
6 Month
+21.0%
+21.0%
1 Year
+18.1%
+18.1%

More News

Read More
AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Via MarketBeat
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
Via Benzinga
Topics ETFs
Navigating the Aftermath: What Lies Ahead for Markets Post-Decline
Via MarketMinute
Topics Economy Stocks
From Record Heights to Pullback: Analyzing the Current Market Correction
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
S&P 500 Healthcare Sector Navigates Mixed Market Waters on October 29, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Navigating the Aftermath: Market Outlook Post-Declines Amidst Trade Truce and Rate Uncertainty
Via MarketMinute
Topics Artificial Intelligence Economy Government
S&P 500: Decoding the Daily Market Pulse on October 29, 2025
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Market Mania: Soaring Investor Confidence Propels Global Indices to Uncharted Heights
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Navigating the Financial Tides: An Investor's Timeless Guide to Bull and Bear Markets
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Bonds
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
Via FinancialNewsMedia
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety
Via Benzinga
Topics Lawsuit
Kenvue Stock Drops After Texas Attorney General Sues Company Alleging Deceptive Marketing Of Tylenol
Via Stocktwits
Topics Government Lawsuit
2 Dividend Stocks to Double Up on Right Now
Via The Motley Fool
Topics Artificial Intelligence Economy
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Market Alarms Blare: Buffett Indicator and Shiller CAPE Ratio Signal Potential 2026 Stock Market Crash
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Market's Perilous Peak: Is the U.S. Stock Market More Overvalued Than Ever?
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Dow Jones Soars to New Record High Amidst Wave of Optimism, Signaling Robust Market Confidence
Via MarketMinute
Topics Artificial Intelligence Economy Energy
3 Healthcare Stocks to Buy Hand Over Fist in October
Via The Motley Fool
Topics Intellectual Property
Warren Buffett's Investing Playbook -- Simplified for First-Time Stock Buyers
Via The Motley Fool
Topics Economy
3 Healthcare Stocks Paying the Highest Dividends of 2025
Via The Motley Fool
Market Minute: Dow Hits Record Highs, S&P 500 Surges Past 6,800 as Inflation Cools
Via MarketMinute
Topics Artificial Intelligence Bonds Economy

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 188.87
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 10/31/25 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 496.48B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 496B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.